HIV latency reversing agents act through Tat post translational modifications
Georges Khoury(The University of Melbourne), Damian F. J. Purcell(The University of Melbourne), Jenny L. Anderson(The Royal Melbourne Hospital), Leigh Harty(The University of Melbourne), Sharon R. Lewin(University of Melbourne), Carolin Tumpach(The University of Melbourne), Michelle Y. Lee(The University of Melbourne), Jonathan Jacobson(The University of Melbourne), Shuang Li(Nanjing Tech University), Talia M. Mota(The Royal Melbourne Hospital)
Cited by 31
Related Papers
Immune checkpoint blockade in infectious diseases
|Nature reviews. Immunology|2017|571
Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
|PLoS Pathogens|2014|509
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
|Nature Medicine|2021|367
A Functional Role for Aβ in Metal Homeostasis? N‐Truncation and High‐Affinity Copper Binding
|Angewandte Chemie International Edition|2015|128
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy
|Science Translational Medicine|2022|101